Gyrodyne (NASDAQ:GYRO) Shares Pass Below 200 Day Moving Average – Should You Sell?

Shares of Gyrodyne , LLC (NASDAQ:GYRO) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $7.52 and traded as low as $5.50. Gyrodyne shares last traded at $5.5060, with a volume of 3,635 shares.

Gyrodyne Price Performance

The company’s 50-day moving average price is $6.17 and its two-hundred day moving average price is $7.52.

Institutional Trading of Gyrodyne

A hedge fund recently bought a new position in Gyrodyne stock. Advisory Services Network LLC bought a new position in shares of Gyrodyne , LLC (NASDAQ:GYRO) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 7,720 shares of the real estate investment trust’s stock, valued at approximately $77,000. Advisory Services Network LLC owned about 0.35% of Gyrodyne as of its most recent SEC filing. Institutional investors own 71.36% of the company’s stock.

Gyrodyne Company Profile

Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.

The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.